|
|
|
|
Hepatitis B Virus Mutations May Predict Risk Of Liver Cancer
Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large...
|
|
|
Hepatitis B Virus Mutations May Predict Risk Of Liver Cancer
Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large...
|
|
|
JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large...
|
|
|
Hepatitis B virus mutations may help predict liver cancer risk
Washington, July 3 : Scientists from Second Military Medical University in Shanghai have revealed that mutations in the DNA of hepatitis B virus (HBV) might help predict which patients are at increased risk of developing liver ...
|
|
|
Hepatitis B virus mutations may help predict liver cancer risk
PM IST Scientists from Second Military Medical University in Shanghai have revealed that mutations in the DNA of hepatitis B virus (HBV) might help predict which patients are at increased risk of developing liver cancer,HBV infection...
|
|
|
Circulating Lamin B1 (LMNB1) Biomarker Detects Early Stages of Liver Cancer in Patients
Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Center for Cancer Research, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, and Quantitative Molecular...
Journal of Proteome Research:
Jul 3 2009 3:06PM
Matching: hepatocellular carcinoma liver cancer
|
Find similar documents
|
|
|
|
Targeted therapy for hepatocellular carcinoma
AbstractHepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide.The major etiologies and risk factors for development of HCC are well defined and some steps of hepatocellular carcinogenesis have...
Nature Clinical Practice Gastroenterology & Hepato:
Jul 3 2009 10:08AM
Matching: hepatocellular carcinoma liver
|
Find similar documents
|
|
|
|
Hepatitis B Virus - Scientists at University of Tokyo target hepatitis B virus
Learn more about a six-week, no-risk free trial of Hepatitis Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Hepatitis B Virus According to recent research published in the...
|
|
|
Hepatocellular Cancer - New findings reported from H.H. Lee and co-authors describe advances in hepatocellular
Learn more about a six-week, no-risk free trial of Hepatitis Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Hepatocellular Cancer New findings reported from H.H....
|
|
|
Hepatocellular Cancer - Findings in hepatocellular cancer reported from University of Genoa
Learn more about a six-week, no-risk free trial of Hepatitis Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Hepatocellular Cancer Findings in hepatocellular...
|
|
|
Hepatitis B Virus - Studies from K. Szymanska et al have provided new data on hepatitis B virus
Learn more about a six-week, no-risk free trial of Hepatitis Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Hepatitis B Virus Studies from K. Szymanska et al have provided...
|
|
|
Small hepatocellular carcinoma: Is radiofrequency ablation combined with transcatheter arterial chemoembolizat
1-, 2-, 3-, and 4-yr rates of LTP, OS, local PFS, and recurrence-free survival were as follows: LTP rates were 14.4%, 17.6%, 17.6%, and 17.6%, respectively, in combined treatment group and 11.4%, 14.4%, 14.4%, and 14.4%, respectively, in...
|
|
|
PROVECTUS PHARMACEUTICALS - Newly Released Company Financials and Credit Information (Published 11th June 2009
www.companiesandmarkets.com/Summary-Company-Financials/provectus ..The Company is a development-stage biopharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical...
|
|
|
JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large...
Genetic Engineering News:
Jul 2 2009 9:28PM
Matching: hepatocellular carcinoma liver cancer
|
Find similar documents
|
|
|
|
Proliferation defects and genome instability in cells lacking Cul4A
The Cul4A gene, which encodes a core component of a cullin-based E3 ubiquitin ligase complex, is overexpressed in breast and hepatocellular cancers.In breast cancers, overexpression of Cul4A strongly correlates with poor...
|
|
|
News Notes: Two Proteins May Be Key to Screening for Early-Stage Liver Cancer
Researchers have identified an improved method of screening high-risk patients for one of the most common types of liver cancer, hepatocellular carcinoma (HCC), particularly if the patient has a history of hepatitis....
National Cancer Institute:
Jul 1 2009 9:28PM
Matching: hepatocellular carcinoma liver cancer
|
Find similar documents
|
|
|
|
Two Proteins May Be Key to Screening for Early-Stage Liver Cancer
Researchers have identified an improved method of screening high-risk patients for one of the most common types of liver cancer, hepatocellular carcinoma (HCC), particularly if the patient has a history of hepatitis....
National Cancer Institute:
Jul 1 2009 1:39PM
Matching: hepatocellular carcinoma liver cancer
|
Find similar documents
|
|
|
|
Progen licenses anti-cancer product
Progen Pharmaceuticals Ltd announced on June 30 that it has licensed its lead anti-cancer product muparfostat, formerly known as PI-88, to US-based Global TransBiotech Inc.The company has strong ties with pharmaceutical companies in...
|
|
|
ProgenEURs Pharmasynth Secures Global Muparfostat License
: Progen Pharmaceuticals Limited (ASX: PGL; NASDAQ: PGLA) today announced that its wholly-owned subsidiary PharmaSynth Pty Ltd has executed a binding agreement with Global TransBiotech Inc for the global licensing of muparfostat, Progens...
|
|
|
Pfizer Discontinues Phase 3 Trial of Sutent in Metastatic Colorectal Cancer
We are disappointed with this result, but trial successes and failures are an integral part of cancer drug development and contribute to a growing body of knowledge on improving patient care, said Dr.Mace Rothenberg, senior vice...
|
|
|
Nationwide Children's Hospital: Study shows promise for new cancer-stopping therapy
Study shows promise for new cancer-stopping therapy Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in...
|
|
|
Glossary of cancer treatment terms
Benign: A growth which is not a cancer, and not a pre-cancer.Being benign is not a guarantee that a growth will not cause problems. For example: in a closed space, such as inside the skull, a benign growth can still cause...
|
|
|
Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal t
Today in CT/SPECT/PET...Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal t.
|
|
|
Small-cell prostate carcinoma: A retrospective analysis of five newly reported cases
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Indian Journal of Urology, 06/26/09 Print Save in My Library Free Full Text Brownback KR et al.- The PSA levels varied greatly, with two patients...
|
|
|
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diab
Statin use may help prevent hepatocellular carcinoma (HCC) in patients with diabetes, according to a new study.Researchers examined data on 1,303 patients with diabetes and HCC and 5,212 controls. About 99 percent of the...
|
